Eufemed https://validator.w3.org/feed/docs/rss2.html Breithaupt-Grögler K, et al. The New First-in-Human EMA Guideline: Disruptive or Constructive? Outcomes From the First EUFEMED Discussion Forum. Hardman T, et al. European Federation for Exploratory Medicines Development Lyon Conference 2019: The Changing Landscape of Early Medicines Development-Be Prepared. Klein J, et al. Healthy participant engagement in early clinical trials: results from the European EUFEMED survey. Publications Protected: 21-23.05.2025 - EUFEMED-HEALIXIA Conference - Mastering increasing complexity in developing innovative therapies Lorem Ipsum is simply dummy JOINING EUFEMED THE EUFEMED BOARD Coming soon - EUFEMED Annual Conference: Exploratory medicines development: innovation and risk management 28.06 – 01.07.2025 – European Association for Clinical Pharmacology and Therapeutics EACPT2025 Helsinki 10 | 13-15 | 20 November 2023 – Module 3, EUFEMED Diploma Course in Human Pharmacology DOWNLOAD PRESENTATIONS: 4th EUFEMED Conference – Mastering the New Time Pressure on Human Pharmacology 12-14.06.2024 – INTRODUCTORY COURSE IN EXPLORATORY MEDICINES DEVELOPMENT 19.06.2024 – AFPT – Club Phase 1 webinar: First-In-Human Dose Selection & Approaches 26.04.2024 – ToxAIcology – AI as the New Frontier in Risk Assessment 14.06.2024 – EUFEMED Webinar: Preferences of Phase I participants Van Bortel L, et al. EUFEMED London Conference 2017: Exploratory Medicines Development: Innovation and Risk Management. Associate Membership Upcoming Full Membership INTRODUCTORY COURSE IN EXPLORATORY MEDICINES DEVELOPMENT – PART I – JANUARY 2020, OBERURSEL, GERMANY News News_old Training 19.10.2017: EUFEMED 2017 DELEGATE FEEDBACK REPORT 21-22.05.2015: EUFEMED ANNUAL CONFERENCE 2015 EUFEMED Symposium at the ACCP Annual Conference 2016 Download presentations of the London conference 2017 24.04.2018: The New First-in-Human EMA Guideline: Disruptive or Constructive? 19.10.2018: EUFEMED FORUM – REVISED FIH EMA GUIDELINE: DISRUPTIVE OR CONSTRUCTIVE? eufemed-conference-lyon-programme 13.05.2022: An overview of changing aspects for national Phase I trials under the EU Clinical Trial Regulation (online) 18.11.2022: Reporting obligations under the clinical trial regulation: SUSARs, serious breaches, summary of trial results and lay summaries (online) Download presentations of the Webinar 3 (18 NOVEMBER 2022) 25-26.05.2023 - 4th EUFEMED Conference: Mastering the New Time Pressure on Human Pharmacology 15.09.2023: Patient/Participant engagement in exploratory clinical development (online) 15.12.2023: EUFEMED Scientific Christmas lecture: The (early) clinical development of new analgesics: the point of view of a pain clinician (online) DOWNLOAD PRESENTATIONS: 4th EUFEMED Conference - Mastering the New Time Pressure on Human Pharmacology 18-22 MAR 2024: “PRE-CLINICAL AND CLINICAL SAFETY IN EARLY DEVELOPMENT HUMAN TRIALS” 2024 20.09.2024 - EUFEMED Workshop: “Making the Investigator Brochure truly fit for purpose in early medicines development” 26.04.2024 - ToxAIcology - AI as the New Frontier in Risk Assessment 13–17.03.2023: "Pre-Clinical and Clinical Safety in Early Development Human Trials" 16.12.2022: The (early) clinical development of new analgesics: the point of view of a pain clinician (online) Download presentations of the Webinar 4 (16 DECEMBER 2022) 18.11.2022: Webinar - Reporting obligations under the Clinical trial Regulation 16.10.2022: Submitting an application for a CTA and what do sponsors from outside the EU need to consider (online) Download presentations of the Webinar 2 (16 SEPTEMBER 2022) Download presentations of the Webinar 1 (13 MAY 2022) 28-30.05.2021: EUFEMED Virtual Annual Conference 2021 Home